Medical News

RSS

U.S.District Court ruling favors Merck in patent infringement suit against Teva Pharmaceuticals

Merck & Co., Inc. announced today that the U.S. District Court for the District of New Jersey has ruled in Merck's favor in a patent infringement suit against Teva Pharmaceuticals USA Inc. (Teva).

20 Aug 2009

Perot Systems to provide back-office functional support to Community Health Plan of Washington

Community Health Plan of Washington (CHP Washington) and Perot Systems Corporation (NYSE: PER) (www.perotsystems.com) today announced an agreement where Perot Systems will provide technology and business process services to improve the Seattle-based health plan's back-office functions. The scope of services to be managed by Perot Systems includes claims processing, claims adjustments, enrollment, premium billing, and configuration.

20 Aug 2009

Amphion Innovations reports interim results for the six months ended 30 June 2009

Amphion Innovations plc (LSE: AMP) (“Amphion” or the “Company”), the developer of medical and technology businesses, today announces its unaudited interim results for the six months to 30 June 2009.

20 Aug 2009

Blankenships receive $6 million compensation for infant son's death due to medical negligence

A couple who alleged that Saint Louis University failed to diagnose and treat a bacterial infection that led to their 6-month-old son’s death were awarded $6 million by a St. Louis jury on Aug. 17. The parents were represented by attorneys David M. Zevan and Kevin J. Davidson of St. Louis-based Zevan & Davidson.

20 Aug 2009

Aton Pharma markets preservative-free drugs for glaucoma

Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced it has launched new education, distribution, sampling and reimbursement programs for TIMOPTIC(R) in OCUDOSE(R), the only preservative-free medication for glaucoma available in the United States. Aton acquired the U.S. marketing rights in February to the TIMOPTIC product line from Merck & Co., Inc. TIMOPTIC (timolol maleate) is a non-selective beta-adrenergic receptor blocking agent indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. As many as 2.25 million Americans suffer from open-angle glaucoma.

20 Aug 2009

Bay Bio joins business leaders to promote research, innovation and development in California

BayBio, Northern California’s life sciences association, joins business leaders at the State Capital to promote innovation, research and development as a cost-effective building block to the Golden State’s economic future. The coalition calls on policymakers to make a concerted effort to develop a manufacturing policy to capture the potential the life sciences offers to California workers.

20 Aug 2009

InterMune receives $20 million event payment from Roche for initiating the Phase 2b trial of RG7227/ ITMN-191

Roche (SIX: ROG.VX; RO.S, OTCQX: RHHBY) and InterMune, Inc. (Nasdaq: ITMN) today announced that the first patient has been dosed in a Phase 2b study evaluating the hepatitis C virus (HCV) protease inhibitor, RG7227/ ITMN-191, in combination with PEGASYS(R) (pegylated interferon alfa-2a) and COPEGUS(R) (ribavirin). The study, to be conducted at 45 sites globally, will further define the safety and efficacy profile of RG7227/ ITMN-191, for a treatment duration of up to 24 weeks. Approximately 300 treatment-naive patients chronically infected with HCV genotype 1 - the most difficult to treat form of the virus - will participate.

20 Aug 2009

Catalent Pharma Solutions completes the first FDA general cGMP audit

Catalent Pharma Solutions announces the recent successful completion of the first FDA general cGMP audit and pre-approval inspection of its Buenos Aires, Argentina pharmaceutical softgel facility, with no reported observations on FDA Form 483.

20 Aug 2009

Wireless patient monitoring systems tends to be more economical according to ABI Research

The market for wireless devices that monitor patients’ condition and report that data to healthcare providers is on the verge of explosive growth, according to a new study from ABI Research. Over the next few years it will show a remarkable 77% compound annual growth rate (CAGR) resulting in global revenue of almost $950 million in 2014.

20 Aug 2009

Childhood vaccination awareness campaign intensified by COSHAR Foundation

The COSHAR Foundation has enhanced its national immunization awareness campaign, Protecting our Future: The COSHAR Foundation Immunization Project, by updating its free immunization toolkits with new materials, including updated information about autism and vaccines and information on H1N1 flu. The new toolkits are available now.

20 Aug 2009

Arizona finalizes health care contract

CIGNA HealthCare announced today that it is one of four companies to have been awarded a contract to provide medical benefits to Arizona's state employees, university employees and retirees. The contract becomes effective October 1, 2009.

20 Aug 2009

Rapid Fire Marketing to change its name to Medical Cannabis Management

Rapid Fire Marketing (Pink Sheets: RFMK) announces plans to provide services to the medical cannabis industry. With the passing of Proposition 215, making medical cannabis legal in the state of California, Rapid Fire Marketing has entered the business of providing full service marketing, consulting and management services to this newly-emerged industry, which includes medical doctors and cannabis dispensaries.

20 Aug 2009

InterMed Discovery acquires microbial Omega-3 fatty acid production strains from the University of Saarland

InterMed Discovery (IMD), a world class natural product lead-discovery company, today announced the acquisition of unique microbial Omega-3 fatty acid production strains and related know-how from the University of Saarland.

20 Aug 2009

Incentive Federation launches campaign on the benefits of health care incentives

With national attention focused on health care, the Incentive Federation recently launched a nationwide effort to convince members of Congress that incentives can improve health care behaviors and reduce spending at the same time they enhance overall health.

20 Aug 2009

Covering Kids & Families Michigan campaign aims to enroll 50,000 children in healthcare coverage plans

As Michigan's children head back to school, the Michigan Cover the Uninsured Network (MCTUN) and some of the state's leading organizations are making a special outreach effort to ensure that eligible children and families have access to free and/or low cost health coverage through the state's Medicaid and MIChild programs.

20 Aug 2009

Supplemental Manufacturing and Ingredients forges manufacturing agreement with HealthSport's subsidiary, InnoZen

InnoZen, Inc., a wholly owned subsidiary of HealthSport, Inc. (OTC Bulletin Board: HSPO) announced today that it has entered into a manufacturing agreement with Supplemental Manufacturing and Ingredients, LLC ("SMI"), a cGMP certified manufacturer based in Tempe, Arizona. As part of the Agreement, SMI has committed to purchasing $1,000,000 worth of HealthSport common stock.

20 Aug 2009

New McKinney office of Hospice Compassus to provide local bereavement support

Hospice Compassus, a leading provider of hospice services, announced today the opening of its third Dallas-area location in McKinney, Texas.

20 Aug 2009

Health Media Network's digital signage system to cover more U.S. markets

Health Media Network (HMN) announced plans to expand its point-of-care digital signage network into major U.S. markets, including Detroit, Miami, St. Louis, Los Angeles and Chicago. The move signals the growing demand for HMN's services by healthcare providers and advertisers. Installations in Miami, Detroit, and St. Louis were recently completed. Expansion to other markets is slated for the second half of 2009. HMN's largest market is New York City, where it owns and operates a network comprising physicians' waiting room areas.

20 Aug 2009

First-quarter fiscal 2010 results announced by Cyberonics

Cyberonics, Inc. today announced results for the quarter ended July 24, 2009. Net sales were $38.5 million, a 14% increase from $33.7 million in the first quarter of fiscal 2009.

20 Aug 2009

Imagenetix announces retail distribution of InflameAway Celadrin(R) gels for promoting joint health

Imagenetix, Inc. (OTC Bulletin Board: IAGX) announced that InflameAway Celadrin(R) extra strength soft gels for joint health are currently available at the nation's number one drug chain, the number one and number two supermarket stores and the number one club warehouse store. This retail distribution provides a platform for future retail gains as well as additional product launches, including a 100 count value size.

20 Aug 2009

Medical News

U.S.District Court ruling favors Merck in patent infringement suit against Teva Pharmaceuticals

Perot Systems to provide back-office functional support to Community Health Plan of Washington

Amphion Innovations reports interim results for the six months ended 30 June 2009

Blankenships receive $6 million compensation for infant son's death due to medical negligence

Aton Pharma markets preservative-free drugs for glaucoma

Bay Bio joins business leaders to promote research, innovation and development in California

InterMune receives $20 million event payment from Roche for initiating the Phase 2b trial of RG7227/ ITMN-191

Catalent Pharma Solutions completes the first FDA general cGMP audit

Wireless patient monitoring systems tends to be more economical according to ABI Research

Childhood vaccination awareness campaign intensified by COSHAR Foundation

Arizona finalizes health care contract

Rapid Fire Marketing to change its name to Medical Cannabis Management

InterMed Discovery acquires microbial Omega-3 fatty acid production strains from the University of Saarland

Incentive Federation launches campaign on the benefits of health care incentives

Covering Kids & Families Michigan campaign aims to enroll 50,000 children in healthcare coverage plans

Supplemental Manufacturing and Ingredients forges manufacturing agreement with HealthSport's subsidiary, InnoZen

New McKinney office of Hospice Compassus to provide local bereavement support

Health Media Network's digital signage system to cover more U.S. markets

First-quarter fiscal 2010 results announced by Cyberonics

Imagenetix announces retail distribution of InflameAway Celadrin(R) gels for promoting joint health

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Latest News